4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001209191-23-057402
Chief Operating Officer sold 3,000 shares at an average $52.14 ($156,408)
- Chief Operating Officer acquired 3,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wassil Jim Chief Operating Officer | 2023-12-01 | Option exercise 10b5-1 | +3,000 | $2.42 | $7,260 | 178,935 | D |
| Wassil Jim Chief Operating Officer | 2023-12-01 | Sale 10b5-1 | −1,067 | $51.46 | $54,908 | 177,868 | D |
| Wassil Jim Chief Operating Officer | 2023-12-01 | Sale 10b5-1 | −1,933 | $52.51 | $101,500 | 175,935 | D |
| Derivatives | |||||||
| Wassil Jim Chief Operating Officer | 2023-12-01 | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 96,555 | D | ||
| Open-market sales · 3,000 sh · avg $52.14 · $156,408 | |||||||
Loading xslF345X05/doc4.xml…